Bay Colony Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$274K Sell
4,279
-44
-1% -$2.89K 0.03% 399
2026
Q1
$308K Sell
4,323
-9,857
-70% -$777K 0.04% 381
2025
Q4
$1.16M Buy
14,180
+9,881
+230% +$770K 0.14% 144
2025
Q3
$323K Sell
4,299
-207
-5% -$15.4K 0.04% 378
2025
Q2
$334K Sell
4,506
-2,861
-39% -$199K 0.05% 322
2025
Q1
$589K Buy
7,367
+70
+1% +$6.02K 0.09% 217
2024
Q4
$571K Buy
7,297
+153
+2% +$13K 0.08% 222
2024
Q3
$670K Buy
7,144
+456
+7% +$38.3K 0.1% 198
2024
Q2
$521K Sell
6,688
-7
-0.1% -$571 0.09% 209
2024
Q1
$609K Buy
6,695
+126
+2% +$10.5K 0.11% 183
2023
Q4
$508K Hold
6,569
0.1% 188
2023
Q3
$447K Sell
6,569
-498
-7% -$36.2K 0.11% 178
2023
Q2
$574K Sell
7,067
-1,018
-13% -$81.2K 0.14% 148
2023
Q1
$664K Buy
+8,085
New +$577K 0.18% 127

Other funds holding GEHC

Bay Colony Advisors's GEHC Position: Q2 2026 in Review

Bay Colony Advisors reduced its GE HealthCare (GEHC) stake by 1% in Q2 2026, selling an estimated $2.89K and leaving 4,279 shares worth $274K. The position accounts for 0.03% of the portfolio, ranked #399.

Bay Colony Advisors first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.16M in Q4 2025. 269 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Bay Colony Advisors held 4,279 shares of GE HealthCare worth $274K as of Q2 2026.
  • Bay Colony Advisors sold 44 GE HealthCare shares in Q2 2026, an estimated $2.89K.
  • GE HealthCare made up 0.03% of Bay Colony Advisors's portfolio in Q2 2026, its #399 holding.
  • Bay Colony Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Bay Colony Advisors's GE HealthCare position peaked at $1.16M in Q4 2025.
  • 269 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Bay Colony Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.